← Eichor
Study identifier: NCT06832436 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Atrial Strain in Septic Shock

Condition: Septic Shock · Left Atrial Strain · Right Atrial Strain  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Septic shock is a critical condition associated with high mortality. Transthoracic echocardiography is widely used to evaluate cardiac function and guide treatment. Left and right atrial strain (LAS and RAS) measured via speckle tracking echocardiography have shown prognostic value in cardiovascular diseases. However, differences exist between echocardiographic software, leading to challenges in result comparability. This study aims to compare LAS and RAS measurements between ECHOPAC and UWS software, evaluate AutoStrain technology, and assess reproducibility across observers. The study is non-interventional and will use retrospective echocardiographic data from patients treated for septic shock. The findings will contribute to improving measurement standardization in critically ill patients.

This description comes directly from the study's public registry record.

Talk to the study team

Christophe Beyls, MD  ·  33+322087866  ·  beyls.christophe@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHRU AmiensSalouël, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06832436